Trial Outcomes & Findings for MRI of Infrapatellar Fat Pad in Osteoarthritis (NCT NCT02829463)

NCT ID: NCT02829463

Last Updated: 2017-06-12

Results Overview

Recruitment status

COMPLETED

Target enrollment

121 participants

Primary outcome timeframe

collect the data within 24 hours after the subjects did the MRI

Results posted on

2017-06-12

Participant Flow

Participant milestones

Participant milestones
Measure
Osteoarthritis Patients
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Healthy Controls
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Overall Study
STARTED
59
62
Overall Study
COMPLETED
59
62
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

MRI of Infrapatellar Fat Pad in Osteoarthritis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Osteoarthritis Patients
n=59 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Healthy Controls
n=62 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Total
n=121 Participants
Total of all reporting groups
Age, Continuous
59.6 years
STANDARD_DEVIATION 9.2 • n=5 Participants
38.8 years
STANDARD_DEVIATION 13.6 • n=7 Participants
49.9 years
STANDARD_DEVIATION 15.6 • n=5 Participants
Sex: Female, Male
Female
36 Participants
n=5 Participants
29 Participants
n=7 Participants
65 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
33 Participants
n=7 Participants
56 Participants
n=5 Participants
BMI
24.7 kg/(m^2)
STANDARD_DEVIATION 3.5 • n=5 Participants
22.6 kg/(m^2)
STANDARD_DEVIATION 4.4 • n=7 Participants
23.6 kg/(m^2)
STANDARD_DEVIATION 4.1 • n=5 Participants

PRIMARY outcome

Timeframe: collect the data within 24 hours after the subjects did the MRI

Outcome measures

Outcome measures
Measure
Osteoarthritis Patients
n=59 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Healthy Controls
n=62 Participants
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
Infrapatellar Fat Pad Volume in MRI
25154.96 mm^3
Standard Deviation 4865.37
29202.39 mm^3
Standard Deviation 7242.63

Adverse Events

Osteoarthritis Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Healthy Controls

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jinshen He

Third Xiangya Hospital of Central South University

Phone: 8613517470997

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place